Skip to main content
. Author manuscript; available in PMC: 2018 Oct 31.
Published in final edited form as: Chem Commun (Camb). 2017 Oct 31;53(87):11948–11951. doi: 10.1039/c7cc07285f

Table 1.

The antibacterial activity of compounds 19.

Cpd MIC (µg/mL)
HC50(µg/mL) AI[b]
Gram Positive Gram Negative

MRSA MRSE VRE E. Coli PA KP
1 >25 ND[a] ND >25 ND ND ND ND
2 >25 ND ND >25 ND ND ND ND
3 12 >25 >25 1.5 >25 >25 ND ND
4 12 >25 >25 3.0 >25 >25 ND ND
5 0.33 0.75 0.75 1.5 12 3.0 140 424
6 3.0 1.5 1.5 3.0 25 3.0 >250 >83
7 0.33 0.75 0.75 1.5 6.0 1.5 >250 >769
8 0.16 0.75 0.75 0.75 4.0 0.75 >250 >1534
9 >25 ND ND 3.0 ND ND ND ND
D[c] 0.5 0.5 1.0 >25 >25 >25
C[d] >25 >25 >25 0.5 1.0 0.5
[a]

ND, Not determined because compounds are not active.

[b]

AI, Activity Index, determined by HC50/MICMRSA.

[c]

D, Daptomycin, is included for comparison against gram-(+) bacteria.

[d]

C, Colistin, was included in the test as the positive control against gram-(−) bacteria.